The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review
Open accessAbstract
During the current global public health emergency caused by novel coronavirus disease 19 (COVID-19), researchers and medical experts started working day and night to search for new technologies to mitigate the COVID-19 pandemic. Recent studies have shown that artificial intelligence (AI) has been successfully employed in the health sector for various healthcare procedures. This study comprehensively reviewed the research and development on state-of-the-art applications of artificial intelligence for combating the COVID-19 pandemic. In the process of literature retrieval, the relevant literature from citation databases including ScienceDirect, Google Scholar, and Preprints from arXiv, medRxiv, and bioRxiv was selected. Recent advances in the field of AI-based technologies are critically reviewed and summarized. Various challenges associated with the use of these technologies are highlighted and based on updated studies and critical analysis, research gaps and future recommendations are identified and discussed. The comparison between various machine learning (ML) and deep learning (DL) methods, the dominant AI-based technique, mostly used ML and DL methods for COVID-19 detection, diagnosis, screening, classification, drug repurposing, prediction, and forecasting, and insights about where the current research is heading are highlighted. Recent research and development in the field of artificial intelligence has greatly improved the COVID-19 screening, diagnostics, and prediction and results in better scale-up, timely response, most reliable, and efficient outcomes, and sometimes outperforms humans in certain healthcare tasks. This review article will help researchers, healthcare institutes and organizations, government officials, and policymakers with new insights into how AI can control the COVID-19 pandemic and drive more research and studies for mitigating the COVID-19 outbreak.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Artificial Intelligence and the Public Sector—Applications and Challenges
Wirtz, B. W., Weyerer, J. C., & Geyer, C. (2019) · International Journal of Public Administration · doi:10.1080/01900692.2018.1498103 · Cited by 1,341 · cited 1×
“Recent studies have shown that artificial intelligence (AI) is a promising technology that can be employed in various sectors such as, in process industries, the agriculture sector, banking, computing, and healthcare (Wirtz et al., 2019; Liu et al., 2020; Abduljabbar et al., 2019).”
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Mei, X., Lee, H.-C., Diao, K.-Y., Huang, M., Lin, B., Liu, C., Xie, Z., Ma, Y., Robson, P. M., Chung, M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0931-3 · Cited by 1,084
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018 · cited 1×
“AI coupled with drug repurposing can detect the drugs that can be (Mak & Pichika, 2019).”
Zhang, K., Liu, X., Shen, J., Li, Z., Sang, Y., Wu, X., Zha, Y., Liang, W., Wang, C., Wang, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.045 · Cited by 917
Nadarzynski, T., Miles, O., Cowie, A., & Ridge, D. (2019) · DIGITAL HEALTH · doi:10.1177/2055207619871808 · Cited by 810
Wahl, B., Cossy-Gantner, A., Germann, S., & Schwalbe, N. R. (2018) · BMJ Global Health · doi:10.1136/bmjgh-2018-000798 · Cited by 796 · cited 1×
“This emerging technology is used in various medical studies and results in better scale-up, timely, most reliable, and efficient outcomes, and sometimes outperforms humans in certain healthcare tasks (Coeckelbergh, 2010; Nadarzynski et al., 2019; Cossy-Gantner et al., 2018).”
Applications of artificial intelligence in transport: An overview
Abduljabbar, R., Dia, H., Liyanage, S., & Bagloee, S. A. (2019) · Sustainability · doi:10.3390/su11010189 · Cited by 769
Artificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636 · cited 1×
“It was identified by the network medicine analysis that Toremifene can significantly be used for treating COVID-19 disease (Zhou et al., 2020).”
Heidari, M., Mirniaharikandehei, S., Khuzani, A. Z., Danala, G., Qiu, Y., & Zheng, B. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104284 · Cited by 423
Pham, Q.-V., Nguyen, D. C., Huynh-The, T., Hwang, W.-J., & Pathirana, P. N. (2020) · IEEE Access · doi:10.1109/access.2020.3009328 · Cited by 413 · cited 1×
“Therefore, the standard methods are not feasible for the rapid diagnosis and tracking of coronavirus disease (Tahamtan & Ardebili, 2020; Ai et al., 2020; Pham et al., 2020).”
Cited by
Worker and workplace Artificial Intelligence (AI) coexistence: Emerging themes and research agenda
Zirar, A., Ali, S. I., & Islam, N. (2023) · Technovation · doi:10.1016/j.technovation.2023.102747 · Cited by 381
Surveillance and response strategies for zoonotic diseases: a comprehensive review
Sharan, M., Vijay, D., Yadav, J. P., Bedi, J. S., & Dhaka, P. (2023) · Science in One Health · doi:10.1016/j.soh.2023.100050 · Cited by 191
Metadata
- Authors
- Khan, M., Mehran, M. T., Haq, Z. U., Ullah, Z., Naqvi, S. R., Ihsan, M., & Abbass, H.
- Venue
- Expert Systems with Applications
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 185
- Pages
- 115695
- ISSN
- 0957-4174 (ISSN-L)
- OpenAlex
- W3189284249
- Cited by
- 204
- References
- 15
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. https://app.cochat.ai/papers/10.1016/j.eswa.2021.115695
- The paper
- Khan, M., Mehran, M. T., Haq, Z. U., Ullah, Z., Naqvi, S. R., Ihsan, M., & Abbass, H. (2021). Applications of artificial intelligence in COVID-19 pandemic: A comprehensive review. Expert Systems with Applications. https://doi.org/10.1016/j.eswa.2021.115695
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.